Edward M. MD Kaye sold $338K of Cytokinetics (CYTK)

Executed Sep 2 2025, disclosed Sep 2 2025, the same day.

Value, as filed

$338K

6,756 sh × $50.00

Executed

Sep 2 2025

the trade date, as filed

Disclosed

Sep 2 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Edward M. MD Kaye Director profile →

Edward M. MD Kaye (Director) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $1.9M of CYTK (28,064 sh × $66.72, as filed), executed Dec 1 2025.

The name

CYTK

Cytokinetics, Incorporated CYTK · Healthcare · 120 filings in 24 months ticker →

Healthcare · Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators an…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Edward M. MD Kaye in CYTK

CYTKSALE Cytokinetics, Incorporated $223K
2,933 sh × $76.09
Exec Jun 1
Filed Jun 1 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $1.9M
28,064 sh × $66.72
Exec Dec 1 2025
Filed Dec 2 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $337K
5,175 sh × $65.08
Exec Nov 11 2025
Filed Nov 12 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $405K
6,757 sh × $60.00
Exec Oct 6 2025
Filed Oct 6 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $369K
6,695 sh × $55.08
Exec Sep 30 2025
Filed Sep 30 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $117K
3,636 sh × $32.10
Exec Jun 5 2025
Filed Jun 5 2025 · 5:30 PM ET